193 related articles for article (PubMed ID: 12012451)
1. Density functional theory and surface enhanced Raman spectroscopy characterization of novel platinum drugs.
Giese B; Deacon GB; Kuduk-Jaworska J; McNaughton D
Biopolymers; 2002; 67(4-5):294-7. PubMed ID: 12012451
[TBL] [Abstract][Full Text] [Related]
2. Interaction of anticancer drug cisplatin with guanine: density functional theory and surface-enhanced Raman spectroscopy study.
Giese B; McNaughton D
Biopolymers; 2003; 72(6):472-89. PubMed ID: 14587070
[TBL] [Abstract][Full Text] [Related]
3. The chemistry of dinuclear analogues of the anticancer drug cisplatin. A DFT/CDM study.
Deubel DV
J Am Chem Soc; 2006 Feb; 128(5):1654-63. PubMed ID: 16448139
[TBL] [Abstract][Full Text] [Related]
4. Formation of carbonato and hydroxo complexes in the reaction of platinum anticancer drugs with carbonate.
Di Pasqua AJ; Centerwall CR; Kerwood DJ; Dabrowiak JC
Inorg Chem; 2009 Feb; 48(3):1192-7. PubMed ID: 19113934
[TBL] [Abstract][Full Text] [Related]
5. EXAFS and IR structural study of platinum-based anticancer drugs' degradation by diethyl dithiocarbamate.
Bouvet D; Michalowicz A; Crauste-Manciet S; Brossard D; Provost K
Inorg Chem; 2006 Apr; 45(8):3393-8. PubMed ID: 16602799
[TBL] [Abstract][Full Text] [Related]
6. Solution behaviour and biomolecular interactions of two cytotoxic trans-platinum(II) complexes bearing aliphatic amine ligands.
Cubo L; Casini A; Gabbiani C; Mastrobuoni G; Messori L; Jiménez-Barbero J; Navarro-Ranninger C; Quiroga AG
Chemistry; 2009 Sep; 15(36):9139-46. PubMed ID: 19655350
[TBL] [Abstract][Full Text] [Related]
7. The gas-phase chemistry of cis-diammineplatinum(II) complexes: a joint experimental and theoretical study.
Springer A; Bürgel C; Böhrsch V; Mitrić R; Bonacić-Koutecký V; Linscheid MW
Chemphyschem; 2006 Aug; 7(8):1779-85. PubMed ID: 16847840
[TBL] [Abstract][Full Text] [Related]
8. Conformational and vibrational study of platinum(II) anticancer drugs: cis-diamminedichloro-platinum(II) as a case study.
Amado AM; Fiuza SM; Marques MP; Batista de Carvalho LA
J Chem Phys; 2007 Nov; 127(18):185104. PubMed ID: 18020667
[TBL] [Abstract][Full Text] [Related]
9. Electrospray ionization tandem mass spectrometric studies of competitive pyridine loss from platinum(II) ethylenediamine complexes by the kinetic method.
Holmes RJ; O'Hair RA; McFadyen WD
Rapid Commun Mass Spectrom; 2000; 14(24):2385-92. PubMed ID: 11114055
[TBL] [Abstract][Full Text] [Related]
10. Bioactive fragments synergically involved in the design of new generation Pt(ii) and Pd(ii)-based anticancer compounds.
Pucci D; Bellusci A; Bernardini S; Bloise R; Crispini A; Federici G; Liguori P; Lucas MF; Russo N; Valentini A
Dalton Trans; 2008 Nov; (43):5897-904. PubMed ID: 19082045
[TBL] [Abstract][Full Text] [Related]
11. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.
Komeda S; Kalayda GV; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
J Med Chem; 2003 Mar; 46(7):1210-9. PubMed ID: 12646031
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of the interactions of cisplatin and carboplatin with nucleotides using UV resonance Raman spectroscopy.
Benson RL; Gustafson TL
Biopolymers; 1993 Nov; 33(11):1631-41. PubMed ID: 8241424
[TBL] [Abstract][Full Text] [Related]
13. Density functional theory characterization and descriptive analysis of cisplatin and related compounds.
Dans PD; Coitiño EL
J Chem Inf Model; 2009 Jun; 49(6):1407-19. PubMed ID: 19463014
[TBL] [Abstract][Full Text] [Related]
14. Raman, surface enhanced Raman spectroscopy, and DFT calculations: a powerful approach for the identification and characterization of 5-fluorouracil anticarcinogenic drug species.
Pavel I; Cota S; Cînta-Pînzaru S; Kiefer W
J Phys Chem A; 2005 Nov; 109(44):9945-52. PubMed ID: 16838911
[TBL] [Abstract][Full Text] [Related]
15. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
Hamberger J; Liebeke M; Kaiser M; Bracht K; Olszewski U; Zeillinger R; Hamilton G; Braun D; Bednarski PJ
Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657
[TBL] [Abstract][Full Text] [Related]
16. Inelastic neutron scattering study of Pt(II) complexes displaying anticancer properties.
de Carvalho LA; Marques MP; Martin C; Parker SF; Tomkinson J
Chemphyschem; 2011 May; 12(7):1334-41. PubMed ID: 21523878
[TBL] [Abstract][Full Text] [Related]
17. The kinetics and mechanisms of the reaction of Mesna with cisplatin, oxiplatin and carboplatin.
Oprea A; Bazzazi H; Kangarloo B; Wolff JE
Anticancer Res; 2001; 21(2A):1225-9. PubMed ID: 11396168
[TBL] [Abstract][Full Text] [Related]
18. Characterization of surface water on Au core Pt-group metal shell nanoparticles coated electrodes by surface-enhanced Raman spectroscopy.
Jiang YX; Li JF; Wu DY; Yang ZL; Ren B; Hu JW; Chow YL; Tian ZQ
Chem Commun (Camb); 2007 Nov; (44):4608-10. PubMed ID: 17989807
[TBL] [Abstract][Full Text] [Related]
19. Three new asymmetric trans-amine(azole)dichloridoplatinum complexes that overcome cisplatin resistance and their reactions with 5'-GMP.
Pantoja E; Gallipoli A; van Zutphen S; Komeda S; Reddy D; Jaganyi D; Lutz M; Tooke DM; Spek AL; Navarro-Ranninger C; Reedijk J
J Inorg Biochem; 2006 Dec; 100(12):1955-64. PubMed ID: 17083978
[TBL] [Abstract][Full Text] [Related]
20. Influence of amine ligands on the aquation and cytotoxicity of trans-diamine platinum(II) anticancer complexes.
Cubo L; Quiroga AG; Zhang J; Thomas DS; Carnero A; Navarro-Ranninger C; Berners-Price SJ
Dalton Trans; 2009 May; (18):3457-66. PubMed ID: 19381408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
